2018 Healthcare IT / Digital Health Funding and M&A Report Bundle

2018 Healthcare IT / Digital Health Funding and M&A Report Bundle


$1,199.00$1,999.00


Bundle and Save ~20%

Get  Quarterly Reports + The Annual Wrap

– Claim Your Deal!


Clear selection

SKU: N/A. Category: .

Mercom Capital Group’s Healthcare IT Funding and M&A Reports are comprehensive, high-quality reports that deliver superior analysis and insight into market trends. These reports give professionals clarity on the financial landscape of the Healthcare IT industry.

As a yearly subscriber, you will save ~20 percent* compared to the cost of purchasing each report individually. You will automatically receive four reports, Q1 through Q3 and the Annual Healthcare IT Funding and M&A Report which includes Q4.

Our reports cover both consumer-centric and patient-centric technologies and sub-technologies, including: Social Health, Mobile Health (mHealth), Telehealth, Personal Health, Rating & Shopping, Health Information Management, Revenue Cycle Management, Service Providers and Security. Click here to see our complete list of technologies.

The Healthcare IT Funding and M&A Reports contain information on market activity displayed in easy-to-digest charts, graphs and tables, as well as data-driven analysis covering:

  • Venture capital funding deals, including top investors, trends, and breakdown charts and graphs by technology, sector, stage and country;
  • Debt and other equity financings;
  • Mergers and acquisitions (M&A), including trends, breakdown charts and graphs by technology and sector;
  • M&A Activity by Technology
  • New Healthcare IT funds;
  • Bankruptcies, restructurings and downsizings.

Each report also contains comprehensive lists of all announced deals and transactions during each quarter:

  • VC funding, debt financing, and other equity financings
  • M&A activity
 * Enterprise user pricing: Q1-$549, Q2-$549, Q3-$549, and Q4/Annual-$999. Total if bought separately = $2,646. Enterprise user subscription price – $1,999.


RELATED PRODUCTS